The Technical Analyst
Microbot Medical Inc [MBOT]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Instruments & Supplies
Microbot Medical Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
0.32% $0.880
America/New_York / 26 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 12.67 mill |
| EPS: | -1.050 |
| P/E: | -0.840 |
| Earnings Date: | May 15, 2024 |
| SharesOutstanding: | 14.40 mill |
| Avg Daily Volume: | 0.102 mill |
| RATING 2024-04-26 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Neutral | |
| P/E: | Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.840 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.03x |
| Company: PE -0.840 | industry: PE 33.06 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$0.224 (-74.53%) $-0.656 |
| Date: 2024-04-26 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.806 - 0.954 ( +/- 8.41%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-02-22 | Diaz-cartelle Juan | Buy | 17 500 | Stock Option (Right to Buy) |
| 2024-02-22 | Sharon Simon | Buy | 17 500 | Stock Option (Right to Buy) |
| 2024-02-22 | Vaknin Rachel | Buy | 17 500 | Stock Option (Right to Buy) |
| 2024-02-22 | Gadot Harel | Buy | 80 000 | Stock Option (Right to Buy) |
| 2024-02-26 | Gadot Harel | Buy | 79 567 | Stock Option (Right to Buy) |
| INSIDER POWER |
|---|
| 94.50 |
| Last 94 transactions |
| Buy: 3 051 480 | Sell: 817 965 |
Forecast:
16:00 - $0.880
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.880
Forecast 2: 16:00 - $0.880
Forecast 3: 16:00 - $0.880
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.880 (0.32% ) |
| Volume | 0.0316 mill |
| Avg. Vol. | 0.102 mill |
| % of Avg. Vol | 30.94 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MBOT
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 14:58 | sell | $1.220 | N/A | Active |
|---|
MBOT
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Latest Press Releases
2024-04-15 08:30:00 - Press Release
Microbot Medical Shares Status Following Recent Geopolitical Events
All regulatory, clinical, operational and pre-commercial activities continue to stay on track despite the on-going situation in israel
2024-02-05 07:30:00 - Press Release
Microbot Medical Submits An Ide Application To Gain Fda Approval To Commence Its Pivotal Clinical Trial In The Us
The investigational device exemption (ide) application follows the completion of multiple activities necessary to file this application the investigational device exemption (ide) application follows the completion of multiple activities necessary to file this application
2024-01-30 07:20:00 - Press Release
Microbot Medical Announces Settlement And Release Agreement, Effectively Resolving All Associated Legal Matters
All of the cash payable to the plaintiffs in the settlement will be covered by microbot's insurance carrier and will not impact company's cash position all of the cash payable to the plaintiffs in the settlement will be covered by microbot's insurance carrier and will not impact company's cash position
2024-01-18 07:20:00 - Press Release
Microbot Medical Expands Us Clinical Infrastructure In Support Of The Upcoming Ide Submission To Commence Its First In Human Clinical Study
Following the recent positive results of its pivotal glp pre-clinical study, the company added a cra to facilitate the company's first in human clinical study following the recent positive results of its pivotal glp pre-clinical study, the company added a cra to facilitate the company's first in human clinical study
2023-12-29 08:00:00 - Press Release
Microbot Medical Announces Exercise Of Outstanding Preferred Investment Options For $2.73 Million In Gross Proceeds Priced At-the-market Under Nasdaq Rules
Braintree, mass., dec. 29, 2023 (globe newswire) -- microbot medical inc. (nasdaq: mbot), developer of the innovative liberty® endovascular robotic surgical system, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding preferred investment options to purchase up to an aggregate of 1,685,682 shares of common stock, having exercise prices ranging from $2.075 to $3.19 per share, issued by microbot in october 2022 and june 2023, at a reduced exercise price of $1.62 per share. the shares of common stock issuable upon exercise of the preferred investment options are registered pursuant to an effective resale registration statement on form s-1 (file no...
Latest News
2024-02-07 11:11:10 - Zacks Investment Research
Microbot Medical (MBOT) Files IDE to Start Human Clinical Study
Microbot Medical (MBOT) files an IDE with the FDA, approval of which will enable the company to proceed with its human clinical study in the United States.
2023-12-10 14:31:09 - InvestorPlace
3 Stocks at the Forefront of Medical Robotics
Every now and then, speculation – within carefully defined limits – may be appropriate, which brings us to the case for medical robotics stocks to buy. Sure, you can gamble on just about anything these days and a non-zero probability exists for their upside.
2023-09-08 10:02:00 - GlobeNewsWire
Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023
The presentation follows successful extensive uses of the Company's endovascular robotic system in pre-clinical studies The presentation follows successful extensive uses of the Company's endovascular robotic system in pre-clinical studies
2023-05-23 14:25:19 - InvestorPlace
3 Undervalued Penny Stocks to Buy for Multi-Bagger Returns
The stock market can provide investors with an unpredictable and thrilling journey, filled with both excitement and anticipation. This article will delve into the peak of that exhilaration – penny stocks, and particularly high return penny stocks which may be undervalued relative to their future potential.
2023-05-23 12:50:24 - MarketBeat
Microbot Medical spikes 150% on its Endovascular Surgical Robot
Microbot Medical Inc. NASDAQ: MBOT stock spiked more than 150% on a massive 194 million share volume on a successful pre-clinical animal study for its LIBERTY surgical robotic system. Shares hit a high of $4.37 intraday before closing at $3.19 on May 22, 2023.
2023-05-23 06:00:00 - PennyStocks
How to Handle Penny Stocks Volatility in 2023
Penny stocks continue to offer incredible opportunities for investors in 2023. As high-growth, micro-cap equities, they have the potential to outperform traditional stocks, particularly given their inherent affordability, which allows for a broader, more diversified portfolio.
2023-05-22 15:33:58 - PennyStocks
Best Penny Stocks Today? 4 With Big News To Watch This Week
I'm sure if you're on this site, you're looking for info on the best penny stocks today. That means researching trends, analyzing data, and reading up on the latest news to formulate a thesis.
2022-09-13 07:00:00 - GlobeNewsWire
Microbot Medical to Review Recent Progress During H.C. Wainwright's 24th Annual Global Investment Conference
Company Continues to Achieve Primary Objectives for its LIBERTY® Robotic System in 2022 Company Continues to Achieve Primary Objectives for its LIBERTY® Robotic System in 2022
2022-08-18 07:00:00 - GlobeNewsWire
Microbot Medical to Present the Self-Cleaning Shunt at the 16th Asian Australasian Congress of Neurological Surgeons
HINGHAM, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that it will be presenting the Company's Self-Cleaning Shunt (SCS) at the 16th Asian Australasian Congress of Neurological Surgeons (AACNS). The AACNS is hosted by the Israel Neurosurgery Society and is being held from September 6th – 8th in Jerusalem, Israel.
2022-01-24 14:16:31 - InvestorPlace
Short Squeeze Stocks: PIXY, MBOT and 3 Others Experts Think Are Ready to Pop
These five top short squeeze stocks are among the stocks that are making positive moves today, as investors go cherry-picking for wins. The post Short Squeeze Stocks: PIXY, MBOT and 3 Others Experts Think Are Ready to Pop appeared first on InvestorPlace.